| Views | |
|---|---|
| Обоснование внедрения антагониста CCR5 в схемы антиретровирусной терапии | 94 |
| February 2026 | March 2026 | April 2026 | May 2026 | June 2026 | July 2026 | August 2026 | |
|---|---|---|---|---|---|---|---|
| Обоснование внедрения антагониста CCR5 в схемы антиретровирусной терапии | 0 | 1 | 2 | 8 | 9 | 4 | 0 |
| Views | |
|---|---|
| 196-198z.pdf | 11 |
| Views | |
|---|---|
| United States | 36 |
| Austria | 19 |
| Russia | 7 |
| Sweden | 6 |
| Ukraine | 3 |
| Vietnam | 3 |
| Germany | 2 |
| United Kingdom | 2 |
| Brazil | 1 |
| Canada | 1 |
| Views | |
|---|---|
| Vienna | 19 |
| Oakland | 9 |
| Houston | 5 |
| Menlo Park | 4 |
| Hanoi | 3 |
| Jacksonville | 3 |
| Mountain View | 3 |
| Ann Arbor | 2 |
| Atibaia | 1 |
| Duluth | 1 |